CTTN and B-cell chronic lymphocytic leukemia: In a prior study, we described that ROR1/cortactin complex contributed to enhanced activation of RhoA in CLL cells.15 Here, we examined in different cellular microenvironments whether this complex could associate with ARHGEF1 to enhance activation of RhoA.